|
1
|
Fucharoen S, Winichagoon P, Siritanaratkul
N, Chowthaworn J and Pootrakul P: α- and β-thalassemia in Thailand.
Ann N Y Acad Sci. 850:412–414. 1998.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Fucharoen S and Winichagoon P:
Hemoglobinopathies in Southeast Asia: Molecular biology and
clinical medicine. Hemoglobin. 21:299–319. 1997.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Thein SL, Winichagoon P, Hesketh C, Best
S, Fucharoen S, Wasi P and Weatherall DJ: The molecular basis of
β-thalassemia in Thailand: Application to prenatal diagnosis. Am J
Hum Genet. 47:369–375. 1990.PubMed/NCBI
|
|
4
|
Winichagoon P, Thonglairoam V, Fucharoen
S, Wilairat P, Fukumaki Y and Wasi P: Severity differences in
β-thalassaemia/haemoglobin E syndromes: Implication of genetic
factors. Br J Haematol. 83:633–639. 1993.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Fucharoen S, Winichagoon P, Pootrakul P,
Piankijagum A and Wasi P: Variable severity of Southeast Asian
β0-thalassemia/Hb E disease. Birth Defects Orig Artic
Ser. 23:241–248. 1987.PubMed/NCBI
|
|
6
|
Fucharoen S, Ketvichit P, Pootrakul P,
Siritanaratkul N, Piankijagum A and Wasi P: Clinical manifestation
of β-thalassemia/hemoglobin E disease. J Pediatr Hematol Oncol.
22:552–557. 2000.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Galanello R and Origa R: β-thalassemia.
Orphanet J Rare Dis. 5(11)2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Nuntakarn L, Fucharoen S, Fucharoen G,
Sanchaisuriya K, Jetsrisuparb A and Wiangnon S: Molecular,
hematological and clinical aspects of thalassemia major and
thalassemia intermedia associated with Hb E-β-thalassemia in
Northeast Thailand. Blood Cells Mol Dis. 42:32–35. 2009.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Yamsri S, Singha K, Prajantasen T,
Taweenan W, Fucharoen G, Sanchaisuriya K and Fucharoen S: A large
cohort of β(+)-thalassemia in Thailand: Molecular,
hematological and diagnostic considerations. Blood Cells Mol Dis.
54:164–169. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Winichagoon P, Fucharoen S, Chen P and
Wasi P: Genetic factors affecting clinical severity in
β-thalassemia syndromes. J Pediatr Hematol Oncol. 22:573–580.
2000.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Laosombat V, Nopparatana C,
Wongchanchailert M and Wiriyasateinkul A: Molecular basis of
β-thalassemia in Thai Muslim patients in the the south of Thailand.
Southeast Asian J Trop Med Public Health. 28 (Suppl 3):S104–S105.
1997.PubMed/NCBI
|
|
12
|
Laosombat V, Fucharoen SP, Panich V,
Fucharoen G, Wongchanchailert M, Sriroongrueng W, Nopparatana C,
Kenpitak K, Maipang M and Fukumaki Y: Molecular basis of
β-thalassemia in the South of Thailand. Am J Hematol. 41:194–198.
1992.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Laosombat V, Wongchanchailert M,
Sattayesevana B and Nopparatana C: Clinical, hematological and
molecular features in Thais with β-Malay/β-thalassemia and
β-Malay/HbE. Southeast Asian J Trop Med Public Health. 28 (Suppl
3):S106–S109. 1997.PubMed/NCBI
|
|
14
|
Nopparatana C, Panich V, Saechan V,
Sriroongrueng V, Nopparatana C, Rungjeadpha J, Pornpatkul M,
Laosombat V and Fukumaki Y: The spectrum of β-thalassemia mutations
in Southern Thailand. Southeast Asian J Trop Med Public Health. 26
(Suppl 1):S229–S234. 1995.PubMed/NCBI
|
|
15
|
Lettre G, Sankaran VG, Bezerra MA, Araújo
AS, Uda M, Sanna S, Cao A, Schlessinger D, Costa FF, Hirschhorn JN
and Orkin SH: DNA polymorphisms at the BCL11A, HBS1L-MYB, and
β-globin loci associate with fetal hemoglobin levels and pain
crises in sickle cell disease. Proc Natl Acad Sci USA.
105:11869–11874. 2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ma Q, Abel K, Sripichai O, Whitacre J,
Angkachatchai V, Makarasara W, Winichagoon P, Fucharoen S, Braun A
and Farrer LA: β-globin gene cluster polymorphisms are strongly
associated with severity of HbE/β(0)-thalassemia. Clin
Genet. 72:497–505. 2007.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Nuinoon M, Makarasara W, Mushiroda T,
Setianingsih I, Wahidiyat PA, Sripichai O, Kumasaka N, Takahashi A,
Svasti S, Munkongdee T, et al: A genome-wide association identified
the common genetic variants influence disease severity in
β0-thalassemia/hemoglobin E. Hum Genet. 127:303–314.
2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Sherva R, Sripichai O, Abel K, Ma Q,
Whitacre J, Angkachatchai V, Makarasara W, Winichagoon P, Svasti S,
Fucharoen S, et al: Genetic modifiers of Hb
E/β0-thalassemia identified by a two-stage genome-wide
association study. BMC Med Genet. 11(51)2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Munkongdee T, Tongsima S, Ngamphiw C,
Wangkumhang P, Peerapittayamongkol C, Hashim HB, Fucharoen S and
Svasti S: Predictive SNPs for β0-thalassemia/HbE disease
severity. Sci Rep. 11(10352)2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Fucharoen S and Weatherall DJ: The
hemoglobin E thalassemias. Cold Spring Harb Perspect Med.
2(a011734)2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Fucharoen S and Winichagoon P: Clinical
and hematologic aspects of hemoglobin E β-thalassemia. Curr Opin
Hematol. 7:106–112. 2000.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Cunningham MJ, Macklin EA, Neufeld EJ and
Cohen AR: Thalassemia Clinical Research Network. Complications of
β-thalassemia major in North America. Blood. 104:34–39.
2004.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Vitrano A, Calvaruso G, Lai E, Colletta G,
Quota A, Gerardi C, Concetta Rigoli L, Pitrolo L, Cuccia L,
Gagliardotto F, et al: The era of comparable life expectancy
between τhalassaemia major and intermedia: Is it time to revisit
the major-intermedia dichotomy? Br J Haematol. 176:124–130.
2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Sripichai O, Makarasara W, Munkongdee T,
Kumkhaek C, Nuchprayoon I, Chuansumrit A, Chuncharunee S,
Chantrakoon N, Boonmongkol P, Winichagoon P and Fucharoen S: A
scoring system for the classification of β-thalassemia/Hb E disease
severity. Am J Hematol. 83:482–484. 2008.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Winichagoon P, Saechan V, Sripanich R,
Nopparatana C, Kanokpongsakdi S, Maggio A and Fucharoen S: Prenatal
diagnosis of β-thalassaemia by reverse dot-blot hybridization.
Prenat Diagn. 19:428–435. 1999.PubMed/NCBI
|
|
26
|
Mirasena S, Shimbhu D, Sanguansermsri M
and Sanguansermsri T: Detection of β-thalassemia mutations using a
multiplex amplification refractory mutation system assay.
Hemoglobin. 32:403–409. 2008.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kesornsit A, Jeenduang N, Horpet D,
Plyduang T and Nuinoon M: Quantitative trait loci influencing Hb F
Levels in Southern Thai Hb E (HBB: c.79G>A) Heterozygotes.
Hemoglobin. 42:23–29. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Nuinoon M, Jeenduang N, Kesornsit A,
Horpet D and Plyduang T: Hematological and molecular
characterization of a novel Hb A2 variant with
homozygous α-thalassemia-2 in a Southern Thai Individual.
Hemoglobin. 41:213–215. 2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Chong SS, Boehm CD, Higgs DR and Cutting
GR: Single-tube multiplex-PCR screen for common deletional
determinants of α-thalassemia. Blood. 95:360–362. 2000.PubMed/NCBI
|
|
30
|
Fucharoen S, Sanchaisuriya K, Fucharoen G,
Panyasai S, Devenish R and Luy L: Interaction of hemoglobin E and
several forms of α-thalassemia in Cambodian families.
Haematologica. 88:1092–1098. 2003.PubMed/NCBI
|
|
31
|
Fucharoen S, Shimizu K and Fukumaki Y: A
novel C-T transition within the distal CCAAT motif of the
Gγ-globin gene in the Japanese HPFH: Implication of
factor binding in elevated fetal globin expression. Nucleic Acids
Res. 18:5245–5253. 1990.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Roy P, Bhattacharya G, Mandal A, Dasgupta
UB, Banerjee D, Chandra S and Das M: Influence of BCL11A,
HBS1L-MYB, HBBP1 single nucleotide polymorphisms and the HBG2 XmnI
polymorphism On Hb F levels. Hemoglobin. 36:592–599.
2012.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Fucharoen S and Winichagoon P:
Haemoglobinopathies in Southeast Asia. Indian J Med Res.
134:498–506. 2011.PubMed/NCBI
|
|
34
|
Yamsri S, Sanchaisuriya K, Fucharoen G,
Sae-Ung N, Ratanasiri T and Fucharoen S: Prevention of severe
thalassemia in Northeast Thailand: 16 years of experience at a
single university center. Prenat Diagn. 30:540–546. 2010.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Winichagoon P, Fucharoen S, Weatherall D
and Wasi P: Concomitant inheritance of α-thalassemia in
β0-thalassemia/Hb E disease. Am J Hematol. 20:217–222.
1985.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Sripichai O, Munkongdee T, Kumkhaek C,
Svasti S, Winichagoon P and Fucharoen S: Coinheritance of the
different copy numbers of α-globin gene modifies severity of
β-thalassemia/Hb E disease. Ann Hematol. 87:375–379.
2008.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Jomoui W, Tepakhan W, Yamsri S, Srivorakun
H, Fucharoen G and Fucharoen S: A novel SNP rs11759328 on Rho
GTPase-activating protein 18 gene is associated with the expression
of Hb F in hemoglobin E-related disorders. Ann Hematol. 99:23–29.
2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Khamphikham P, Sripichai O, Munkongdee T,
Fucharoen S, Tongsima S and Smith DR: Genetic variation of
Krüppel-like factor 1 (KLF1) and fetal hemoglobin (HbF) levels in
β0-thalassemia/HbE disease. Int J Hematol. 107:297–310.
2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Azman NF, Abdullah WZ, Hanafi S, Diana R,
Bahar R, Johan MF, Zilfalil BA and Hassan R: Genetic polymorphisms
of HbE/β-thalassemia related to clinical presentation: Implications
for clinical diversity. Ann Hematol. 99:729–735. 2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Zarghamian P, Azarkeivan A, Arabkhazaeli
A, Mardani A and Shahabi M: Hepcidin gene polymorphisms and iron
overload in β-thalassemia major patients refractory to iron
chelating therapy. BMC Med Genet. 21(75)2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Torres FF, Bernardo VS, Silva DGH, Okumura
JV and Bonini-Domingos CR: Association of FOXO3 polymorphism
(rs3800231) and clinical subphenotypes of β-thalassemic
individuals. Hematol Transfus Cell Ther: Nov 22, 2020 (Epub ahead
of print).
|
|
42
|
Kumar R, Kaur A and Agarwal S: Influence
of Xmn 1(G)γ (HBG2 c.-211 C → T) globin gene
polymorphism on phenotype of Thalassemia patients of North India.
Indian J Hematol Blood Transfus. 30:286–290. 2014.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Bandyopadhyay S, Roychowdhury K, Chandra
S, Das M and Dasgupta UB: Variable severity of β-thalassemia
patients of Eastern India: Effect of α-thalassemia and XmnI
polymorphism. Clin Exp Med. 1:155–159. 2001.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Colah RB and Gorakshakar A: Control of
thalassemia in India. Thalass Rep. 4(1955)2014.
|
|
45
|
Zhuang J, Zhang N, Wang Y, Zhang H, Zheng
Y, Jiang Y, Xie Y and Chen D: Molecular characterization analysis
of thalassemia and hemoglobinopathy in Quanzhou, Southeast China: A
large-scale retrospective study. Front Genet.
12(727233)2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Yin A, Li B, Luo M, Xu L, Wu L, Zhang L,
Ma Y, Chen T, Gao S, Liang J, et al: The prevalence and molecular
spectrum of α- and β-globin gene mutations in 14,332 families of
Guangdong Province, China. PLoS One. 9(e89855)2014.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Kattamis A, Forni GL, Aydinok Y and
Viprakasit V: Changing patterns in the epidemiology of
β-thalassemia. Eur J Haematol. 105:692–703. 2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Nopparatana C, Nopparatana C, Saechan V,
Karnchanaopas S and Srewaradachpisal K: Prenatal diagnosis of α-
and β-thalassemias in southern Thailand. Int J Hematol.
111:284–292. 2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Abdullah UYH, Ibrahim HM, Mahmud NB,
Salleh MZ, The LK, Noorizhab MNFB, Zilfalil BA, Jassim HM, Wilairat
P and Fucharoen S: Genotype-phenotype correlation of β-thalassemia
in Malaysian population: Toward effective genetic counseling.
Hemoglobin. 44:184–189. 2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Sinha S, Black ML, Agarwal S, Colah R, Das
R, Ryan K, Bellgard M and Bittles AH: Profiling β-thalassaemia
mutations in India at state and regional levels: Implications for
genetic education, screening and counselling programmes. Hugo J.
3:51–62. 2009.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Yamsri S, Pakdee N, Fucharoen G,
Sanchaisuriya K and Fucharoen S: Molecular Understanding of
Non-Transfusion-Dependent Thalassemia Associated with hemoglobin
E-β-Thalassemia in Northeast Thailand. Acta Haematol. 136:233–239.
2016.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Bashyam MD, Chaudhary AK and Bhat V: The
IVS-II-837 (T>G) Appears to be a Relatively Common ‘Rare’
β-Globin Gene Mutation in β-Thalassemia patients in Karnataka
State, South India. Hemoglobin. 36:497–503. 2012.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Liu D, Zhang X, Yu L, Cai R, Ma X, Zheng
C, Zhou Y, Liu Q, Wei X, Lin L, et al: KLF1 mutations are
relatively more common in a thalassemia endemic region and
ameliorate the severity of β-thalassemia. Blood. 124:803–811.
2014.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Perseu L, Satta S, Moi P, Demartis FR,
Manunza L, Sollaino MC, Barella S, Cao A and Galanello R: KLF1 gene
mutations cause borderline HbA2. Blood. 118:4454–4458.
2011.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Borgna-Pignatti C, Rugolotto S, De Stefano
P, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL,
Gamberini MR, Ghilardi R, et al: Survival and complications in
patients with thalassemia major treated with transfusion and
deferoxamine. Haematologica. 89:1187–1193. 2004.PubMed/NCBI
|
|
56
|
Taher AT, Bou-Fakhredin R, Kattamis A,
Viprakasit V and Cappellini MD: Improving outcomes and quality of
life for patients with transfusion-dependent β-thalassemia:
Recommendations for best clinical practice and the use of novel
treatment strategies. Expert Rev Hematol. 14:897–909.
2021.PubMed/NCBI View Article : Google Scholar
|
